Often assisting in the ICP determination process, we do primary market research and examine customer feedback and pain issues available in social media or other sources of such information to acquire insights to deliver a complete customer analysis.
Changes in consumer preferences for sources of information, influencing variables in decision-making, and socioeconomic trends, as well as the reasons for selecting particular brands, goods, or services, are essential for the life sciences and healthcare business to monitor. Our clients benefit from these insights since they enable them to better position their items in the market and increase sales. Our clients also use this information to provide their marketing and sales teams with a competitive edge by basing strategy execution on solid consumer knowledge.
We help our clients to compare themselves with competitors and identify their areas of strengths, weaknesses, and areas for improvement, allowing them to enhance their brand positioning and reputation management strategies.
We help our clients understand customers’ needs by gathering feedback from current and potential customers. These assessments can help understand the pain points, challenges, and requirements of life sciences & healthcare providers, researchers, and payers to align products and services accordingly.
We help uncover changes in the customer journey from interest, information gathering, and purchase, as well as identify the stakeholders involved as influencers, decision-makers, and end users to provide valuable insights to help our clients better position their services to their current and prospective customers.
Why SGA
Industry Leaders
SGA thrives by its brand promise Lifes Possible and is recognized as the trusted life sciences & healthcare business consulting and services provider company in the U.S.
12+ Languages
Multilingual capabilities include Mandarin, Cantonese, Korean, German, Spanish, Arabic, Bahasa, Hindi, Bengali, and English (U.S. & U.K.) experts (either in-house or partnerships).
Data-Driven Insights
With in-depth domain knowledge and proven capabilities of delivering monetizable insights, we deliver high-quality, efficient outputs.
End-To-End Solutioning
The in-house KOL capability of more than 700, along with in-house capabilities of primary market research, financial research, data analytics, engineering, IT, and ESG research and consulting, helps to present credible competitive information.
White Papers
Emergence of Novel Immune - Mediated Therapies
Immunotherapy has emerged as a promising treatment for cancer, with immune checkpoint inhibitors (ICIs) dominating the market. The market is projected to...
White Papers
Future Trends and Technological Advances in Vaccine Treatment and Disease Prevention
The introduction of vaccines for key diseases, such as meningococcal meningitis A, hepatitis E, and malaria, in recent years has helped to reduce mortality...
White Papers
Market Entry in 2023: Why Must You Also Look at Markets Other Than the US and Japan?
Due to dollar fluctuations and the likelihood of market recession, investors and manufacturers of medical devices and pharma are exploring new opportunities...
CASE STUDIES
We strongly believe in equal opportunity for all. Our research team consists of more females than males i.e., 55 % females, and consists of PhDs, M Pharms, D Pharms, Postgraduate in finance, Biotech postgraduates, and MBAs.
